Ask AI
Eunice S. Wang

Eunice S. Wang, MD

Chief, Leukemia Service
Professor of Oncology
Department of Medicine
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Explore Activities by Eunice S. Wang

Title
Format
Credit Type
Credits
Expert Perspectives With FLT3-Mutated AML Testing and Treatment: Challenges and Opportunities

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Key Studies in Hematologic Malignancies: Independent Conference Coverage of the 2024 ASCO Annual Meeting

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Myeloid Malignancies Clinical Advances Journal Club on Emerging Data for AML: Answers to Frequently Asked Questions

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Congress to Clinic: Myeloid Malignancies Clinical Advances Journal Club on Emerging MPN, MDS, and AML Data

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
Congress to Clinic: Expert Takeaways on Emerging Data for MDS

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Congress to Clinic: Expert Takeaways on Emerging Data for AML

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Conference to Clinic: Hematologic Malignancies

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
Emerging Data in AML

Content Format:

Slideset

Credit Type:

--

Credits:

--
Conference to Clinic: Leukemias

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
An Expert’s Guide to ASCO 2024: Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Key Studies in Leukemias and Myelodysplastic Syndromes: Independent Conference Coverage of ASH 2023

Content Format:

Text Module

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Conference to Clinic: Expert Analysis of the 2023 ASH Top Abstracts

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

4.75
Clinic-Ready Insights From the Top Abstracts Presented at the 2023 Annual Hematology Meeting: Leukemias and Myelodysplastic Syndromes

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Conference to Clinic: Leukemias and Myelodysplastic Syndromes

Content Format:

Slideset

Credit Type:

--

Credits:

--
An Expert’s Guide to ASH 2023: Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Key Studies in Hematologic Malignancies: Independent Conference Coverage of the 2023 ASCO Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.50
Conference to Clinic: Expert Analysis of the Top Hematologic Malignancies Abstracts From the 2023 Oncology Meeting in Chicago

Content Format:

Video

Credit Type:

AMA

Credits:

1.25
Conference to Clinic: Leukemias

Content Format:

Slideset

Credit Type:

--

Credits:

--
An Expert’s Guide to ASCO 2023: Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Key Studies in Leukemias: Independent Conference Coverage of ASH 2022

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
An Expert’s Guide to ASH 2022: Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Key Studies in Hematologic Malignancies: Independent Conference Coverage of the 2022 ASCO Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.50
An Expert’s Guide to ASCO 2022: Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Key Studies in Leukemias: Independent Conference Coverage of ASH 2021

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Expert Guidance on Treatment Advances in Acute Myeloid Leukemia

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
ExpressPoints:Acute Myeloid Leukemia: Evidence-Based Guidance on Current Paradigms and New Therapeutic Approaches

Content Format:

Slideset

Credit Type:

--

Credits:

--
An Expert’s Guide to ASH 2021: A Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Expert Guidance on Treatment Advances in Acute Myeloid Leukemia

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Key Studies in Hematologic Malignancies: Independent Conference Coverage of the 2021 ASCO Scientific Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.25
ExpressPointsExploring an Expanding AML Therapeutic Armamentarium: Expert Guidance to Optimize Outcomes

Content Format:

Slideset

Credit Type:

--

Credits:

--
New and Novel Advances in AML Therapeutics

Content Format:

Slideset

Credit Type:

--

Credits:

--
An Expert’s Guide to ASCO 2021: A Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Expert Selections From ASH 2020: Acute and Chronic Myeloid Leukemias

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Expert Insights on Key Data From ASH 2020 on Acute and Chronic Leukemias

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Key Studies in Leukemias: Independent Conference Coverage of ASH 2020

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.25
An Expert’s Guide to ASH 2020: A Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
New Insights in Hematologic Malignancies and Disorders: Independent Conference Coverage of the 2019 ASH Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Combining Chemotherapy With Immunotherapy to Treat ALL: A Novel Approach

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Leukemias: Key Trials From ASH 2019

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
When and How to Assess Genomic and Molecular Alterations in AML: Which Mutations Matter?

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Preview of ASH 2019: Key Expert-Selected Studies

Content Format:

Clinical Thought

Credit Type:

AMA

Credits:

1.00
Research Focus: Targeting the MCL-1 Pathway With CDK9 Inhibitors in AML

Content Format:

Slideset

Credit Type:

AMA

Credits:

1.00
Improving Outcomes With New Therapies for Patients With Acute Myeloid Leukemia

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Moving Toward Precision Therapy for Patients With AML: Clinical Challenges and Future Directions

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.25
Exploring New Therapeutic Frontiers in AML: Emerging Molecular Targets

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--